SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-438287
Filing Date
2013-11-12
Accepted
2013-11-12 16:17:27
Documents
12
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d588560d10q.htm 10-Q 394239
2 EX-10.1 d588560dex101.htm EX-10.1 202640
3 EX-31.1 d588560dex311.htm EX-31.1 8964
4 EX-31.2 d588560dex312.htm EX-31.2 9035
5 EX-32.1 d588560dex321.htm EX-32.1 5654
12 GRAPHIC g588560tx_pg01.jpg GRAPHIC 2058
  Complete submission text file 0001193125-13-438287.txt   3175307

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snss-20130930.xml EX-101.INS 403657
7 XBRL TAXONOMY EXTENSION SCHEMA snss-20130930.xsd EX-101.SCH 31632
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20130930_cal.xml EX-101.CAL 50188
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20130930_def.xml EX-101.DEF 79315
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20130930_lab.xml EX-101.LAB 250386
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20130930_pre.xml EX-101.PRE 162994
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 131210379
SIC: 2834 Pharmaceutical Preparations